Clinical-radiomics predictors to identify the suitability of transarterial chemoembolization treatment in intermediate-stage hepatocellular carcinoma: A multicenter study-Reference-Cited by-同舟云学术

Clinical-radiomics predictors to identify the suitability of transarterial chemoembolization treatment in intermediate-stage hepatocellular carcinoma: A multicenter study

Published:2022-11 Issue: Volume: Page:
ISSN:1499-3872
Container-title:Hepatobiliary & Pancreatic Diseases International
language:en
Short-container-title:Hepatobiliary & Pancreatic Diseases International

Author:

Wang Dan-Dan,Zhang Jin-Feng,Zhang Lin-Han,Niu Meng,Jiang Hui-Jie,Jia Fu-Cang,Feng Shi-Ting

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference50 articles.

1. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;CA Cancer J Clin,2021

2. Primary liver cancers: intrahepatic cholangiocarcinoma and hepatocellular carcinoma;Mejia;Surg Clin N Am,2020

3. Diagnosis, staging, and management of hepatocellular carcinoma: 2018 practice guidance by the American Association for the Study of Liver Diseases;Marrero;Hepatology,2018

4. Global patterns of hepatocellular carcinoma management from diagnosis to death: the BRIDGE Study;Park;Liver Int,2015

5. Hepatocellular carcinoma;Villanueva;N Engl J Med,2019

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Radiomics as a tool for prognostic prediction in transarterial chemoembolization for hepatocellular carcinoma: a systematic review and meta-analysis;La radiologia medica;2024-07-26

2. Conversion therapy for advanced hepatocellular carcinoma in the era of precision medicine: Current status, challenges and opportunities;Cancer Science;2024-05-02

3. Application of Radiomics in the Efficacy Evaluation of Transarterial Chemoembolization for Hepatocellular Carcinoma: A Systematic Review and Meta-analysis;Academic Radiology;2024-01

4. Machine Learning Combined with Radiomics Facilitating the Personal Treatment of Malignant Liver Tumors;Biomedicines;2023-12-26